HealthGlobal
Surging Off-Label Testosterone Prescriptions for Women Face Growing Insurance Denials and Delays
A sharp rise in off-label testosterone prescriptions for perimenopausal and menopausal women is meeting heightened resistance from insurers and pharmacies. As clinical interest in female androgen therapy grows, regulatory gaps leave patients navigating administrative gridlock and steep out-of-pocket costs.
